• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

$15000 Zurzuvae!!





What’s going on with all the sudden job openings for this drug? Heard that they did those people dirty after having them wait around for several months for this launch. Is that true?
 




Interesting that no one is talking about this situation …so many “random” openings now. Sounds like a complete disaster. “Leadership” sounds horrible (from what I’ve heard), incompetent, and keeps lying to the reps about the start date. Good luck to those that are still around. Sounds like fun!